Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous autologous bone marrow mesenchymal stem cells for acute traumatic spinal cord injury (AIS D)
jRCT2013210007Recruiting
- Sponsor
- Nipro Corporation
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of milciclib in acute spinal cord injury (SCI), sponsored by Nipro Corporation. Started Apr 2021; status: recruiting.
02
Drugs
milciclib
03
Conditions
acute spinal cord injury (SCI)
Beyond the preview
Go deeper on jRCT2013210007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2013210007.